Viewing Study NCT03817658


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2026-01-07 @ 11:19 AM
Study NCT ID: NCT03817658
Status: UNKNOWN
Last Update Posted: 2019-01-25
First Post: 2019-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: SHR-1210--01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View